Highlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs Podcast By  cover art

Highlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs

Highlights From ATS 2025: New and Emerging Therapies, Biomarkers, and Imaging for ILDs

Listen for free

View show details

About this listen

Drs. Zaman and Podolanczuk discuss data for new and emerging therapies for ILD presented at ATS 2025, including nerandomilast, inhaled therapies for IPF and ILD, TNIK inhibitors, as well as new biomarkers and imaging for diagnosing ILDs.
No reviews yet